Press release
Global Peptide Based Cancer Therapeutics Market to grow at CAGR of 9.2% through 2022
Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn.For detailed insights on enhancing your product footprint, request for a sample here https://www.factmr.com/connectus/sample?flag=S&rep_id=179
Incessant development in drug modification, stability, delivery and preclinical achievements is reflecting positively on the future prospects of the global peptide based cancer therapeutics market. Of late, an array of new peptides with encouraging preclinical results are undergoing clinical trials for treating cancer. At the same time, these new peptide are also finding application in various other therapeutic areas. Also, increasing occurrence of cancer is anticipated to be instrumental in boosting the demand for peptide based cancer therapeutics in the near future.
As per WHO, over 8 million deaths were recorder globally due to cancer in 2015. Cancer remains one of the foremost causes of death around the world. Factors mentioned above are projected to make a significant influence on the global market for peptide based cancer therapeutics over the forecast period. Moreover, low potency of conventional cancer therapeutics and the adverse side-effects from these therapeutics is prompting physicians to utilise other options. This, in turn, is facilitating the adoption of new-age peptide based therapeutic drugs.
For critical insights on this market, request for methodology here https://www.factmr.com/connectus/sample?flag=RM&rep_id=179
Forecast Highlights Of Global Market For Peptide Based Cancer Therapeutics
• Among regions, North America is expected to remain the most attractive market for peptide based cancer therapeutics during the forecast period. This is largely due to the existence of several prominent peptide based cancer therapeutic drug makers and an advanced healthcare infrastructure in the region. Over the next couple of years, the region’s market is projected to witness a healthy growth. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) is anticipated to register the fastest CAGR over 2022.
• Based on drugs, demand for bortezomib is expected to remain relative higher as compared to other peptide based cancer therapeutic drugs. Revenues from global sales of bortezomib drugs currently commands for nearly 40% market share. Towards the end of 2022, more than US$ 4,700 Mn worth bortezomib drugs are estimated to be sold worldwide.
• Hospital pharmacies are the largest distribution channel for peptide based cancer therapeutic drugs followed by retail pharmacies. Currently, hospital pharmacies account for close to 50% share of the global market in terms of revenue. The trend is likely to continue in 2017 and beyond.
For in-depth competitive analysis, buy now https://www.factmr.com/checkout/179/S
Competition Tracking
Valeant Pharmaceuticals International, Inc., Allergan plc, AbbVie Inc., AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Abbott, Pfizer Inc., and Johnson & Johnson are among the leading companies functioning in the global market for peptide based cancer therapeutics. Majority of these market players are actively focusing on further product development as well as channelizing their investments in R&D activities.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/179/peptide-based-cancer-therapeutics-market
Content Source: https://www.factmr.com/media-release/169/peptide-based-cancer-therapeutics-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peptide Based Cancer Therapeutics Market to grow at CAGR of 9.2% through 2022 here
News-ID: 2263368 • Views: …
More Releases from Fact.MR
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,…
More Releases for Unit
Global Transcutaneous Electrical Nerve Stimulation Unit Market, Transcutaneous E …
Global Transcutaneous Electrical Nerve Stimulation Unit Market Overview:
The Transcutaneous Electrical Nerve Stimulation Unit market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Transcutaneous Electrical Nerve Stimulation Unit market has experienced significant growth, driven by factors such as increasing consumer demand,…
Glycol Dehydration Unit Market Glycol Dehydration Unit Market 2028
Persistence Market Research delivers key insights on the global glycol dehydration unit market, in its report titled, 'Glycol Dehydration Unit Market: Global Industry Analysis 2013-2017 and Forecast 2018-2028'. Over the forecast years, the global glycol dehydration unit market is expected to show a positive outlook.
The market value is expected to increase at a healthy pace over the forecast period. Based on the glycol type segment, the triethylene glycol segment is…
Biodiesel Processing Unit
While reserves of petroleum are decreasing every passing day, energy consumption is increasing at 6.5% per annum. And for solving this issue many countries are implementing new policies for minimizing the usage of fossil fuels and increase the use of alternative sources like solar power and Biodiesel. Biodiesel is a diesel fuel substitute made from a variety of oils, fats, and greases which can become a cheaper alternative to fossil…
Jackfruit Processing Unit
The fruit processing sector has some undoubtedly potential Business Ideas, and Jackfruits processing is highly recommended because jackfruits are highly perishable tropical fruits, which helps in improving the immunity, replenishes the energy, cardiovascular health, regulates Blood Pressure, Digestion, treats the skin diseases, prevent/control asthma and many more awesome advantages of jackfruit consumption.
Rising demand for processed fruit product for secondary preparations, rising income, and resultant increased spending on food items is…
Pomegranate Processing unit
India is the second largest producer of Pomegranates in the world after Iran, still contributes only 5% pomegranate related international trades. India produces the finest edible Pomegranates, which are available almost throughout the year, which provides a tremendous potential for export of Pomegranate and its products from India.
Processing of the Pomegranates becomes essential in order to increase the utilization and reduce the wastage of the fruit. Pomegranates being rich in…
Coconut Processing Unit
Coconut is an important fruit in the Indian economy as the country is listed among the top Coconut producing countries in the world. The contribution of Coconut is about ₹27900 crore to India’s Gross Domestic Product (GDP).
Today's improved economic stability, spending power, nutritional requirements, and awareness are pushing consumers to shift their preferences.
Currently, Coconut water, Coconut milk/cream and Virgin Coconut Oil (VCO) are expected to be main growth drivers for…
